PDCD1 and acute myeloid leukemia: In T cells and CAR‐T cells from AML patients, the expression of activated CD69 and HLA‐DR as well as the markers of exhaustion PD1 and LAG3 was increased, leading to a decrease in antitumor efficacy.316